purpose: to determine the visual and anatomical outcomes and complications of vitrectomy for non-traumatic non-diabetic vitreous hemorrhage (ndvh) and to report the causes of the condition among patients at labbafinejad medical center, tehran-iran, from 1993 to 2003. method: records of patients who underwent vitrectomy for non-traumatic ndvh with 6 months follow up were reviewed for demographic...

OBJECTIVES To investigate CD4-CD8 and CD28 expression in T cells infiltrating the vitreous fluid in patients with proliferative diabetic retinopathy and to evaluate the relationship between the infiltrating T cells and both the activity of proliferative diabetic retinopathy and the clinical outcome. METHODS Both vitreous and peripheral blood samples were obtained simultaneously from 20 consec...

PURPOSE To compare the hemostatic effect of sulfur hexafluoride 20% (SF6 20%) with lactated Ringer's solution for prevention of early postoperative vitreous hemorrhage following diabetic vitrectomy. METHODS In a prospective randomized clinical trial, 50 eyes undergoing diabetic vitrectomy were divided into two groups. At the conclusion of surgery, in one group the vitreous cavity was filled w...

PURPOSE To evaluate the efficacy of intravitreal triamcinolone acetonide (IVT) for the management of postvitrectomy diabetic vitreous hemorrhage. METHODS The authors conducted a retrospective study of patients with postvitrectomy diabetic vitreous hemorrhage who were administered 4 mg (0.1 cc) of triamcinolone acetonide ophthalmic suspension. Ocular history, adverse events, BCVA, intraocular ...

normal 0 false false false en-us x-none ar-sa microsoftinternetexplorer4 background: to investigate the reasons for p ostvitrectomy diabetic vitreous hemorrhage (pdvh), and to analyze the time of pdvh onset, the treatment of pdvh, the visual outcome of the treatment, and factors that affect visual acuity after treatment. materials and methods: overall, 292 eyes from 236 patients with proliferat...

PURPOSE To report the short term anatomical and visual acuity response after intravitreal injection of bevacizumab in patients with proliferative diabetic retinopathy. METHODS Ten eyes having proliferative diabetic retinopathy were treated with at least one intravitreal injection of bevacizumab, 1.25 mg in 0.05 mL. Patients underwent complete ophthalmologic evaluation at baseline and follow u...

INTRODUCTION Vitreous hemorrhage is one of the most common differential diagnoses of sudden painless decrease in vision. OBJECTIVE To find out the etiology of vitreous hemorrhage in cases of vitreous hemorrhage at a tertiary eye centre in Nepal. MATERIALS AND METHODS This was a hospital-based cross-sectional study done over a period of one-and-a-half years. One hundred and one subjects with...

OBJECTIVE To evaluate the visual outcomes of 27-gauge transconjunctival sutureless vitrectomy surgery and its complications in patients with diabetic vitreous hemorrhage. METHODS A quasi-experimental study was conducted where eighty seven eyes of 87 uncontrolled type II diabetes mellitus patients presenting with diabetic vitreous hemorrhage were selected to undergo 27-gauge transconjunctival ...

OBJECTIVE To evaluate the expression of connective tissue growth factor (CTGF) and its fragments in the vitreous of patients with proliferative diabetic retinopathy (PDR) and to localize CTGF expression in associated preretinal membranes. RESEARCH DESIGN AND METHODS Vitreous was obtained from 24 patients with active PDR, 4 patients with quiescent PDR, and 23 patients with other retinal diseas...

Advanced diabetic retinopathy with vitreous hemorrhage or tractional retinal detachment (TDR) is an important cause of severe visual loss in patients with proliferative diabetic retinopathy (PDR), frequently representing an indication for pars plana vitrectomy in diabetic patients. In these cases, surgery is not free from complications such as intraoperative vitreous hemorrhage and retinal rupt...